Detail page

Knowledge Web

Person

Hans H. Kreipe (1956-)

Arzt

Name	Hans H. Kreipe
Time	1956- (Date of birth and death)
Place	Hannover (Wirkungsort) Deutschland
Academic degree	Prof. Dr. med.
Profession	Arzt (characteristic profession) Pathologe
Variant	Hans-Heinrich Kreipe Hans Kreipe H. Kreipe
Related	Medizinische Hochschule Hannover. Institut für Pathologie (Direktor) Medizinische Hochschule Hannover
Further information	Direktor des Instituts für Pathologie der Medizinischen Hochschule Hannover
Record type	Person
GND-Identifier	113369506
Record ID	113369506
Involved in show all Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2024 Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2024 ESR1 Liquid Biopsy im metastasierten Mammakarzinom bei endokriner Resistenz Lehrbuch Pathologie Pathologie : das Lehrbuch AGO-Empfehlungen zur operativen Therapie des Mammakarzinoms: Update 2022 AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2023 Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2023 AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer: update 2023 Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer : Update 2023 Arbeitsgemeinschaft Gynäkologische Onkologie recommendations for the diagnosis and treatment of patients with early breast cancer: update 2023 Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial ERBB2 mutation is associated with sustained tumor cell proliferation after short-term preoperative endocrine therapy in early lobular breast cancer The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer—a pooled analysis of the randomised clinical trials PlanB and SUCCESS C AGO-Empfehlungen zur operativen Therapie der Axilla nach neoadjuvanter Chemotherapie: Update 2021 AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2022 AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2022 Ago recommendations for the surgical therapy of breast cancer: update 2022 AGO Recommendations for the surgical therapy of breast cancer: update 2022 Inter‐observer agreement for the histological diagnosis of invasive lobular breast carcinoma Correction: AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2021 AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2021 AGO Recommendations for the diagnosis and treatment of patients with early breast cancer: update 2021 AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer : update 2021 AGO recommendations for the surgical therapy of the axilla after neoadjuvant chemotherapy: 2021 Update AGO recommendations for the surgical therapy of the Axilla after neoadjuvant chemotherapy: 2021 update AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update Immune cell composition and functional marker dynamics from multiplexed immunohistochemistry to predict response to neoadjuvant chemotherapy in the WSG-ADAPT-TN trial Association of TILs with clinical parameters, Recurrence Score® results, and prognosis in patients with early HER2-negative breast cancer (BC)—a translational analysis of the prospective WSG PlanB trial The run-in phase of the prospective WSG-ADAPT HR+/HER2-trial demonstrates the feasibility of a study design combining static and dynamic biomarker assessments for individualized therapy in early breast cancer Correction to: Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial AGO recommendations for the diagnosis and treatment of patients with early breast cancer: Update 2019 AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer: Update 2019 Knochenmark, Lymphatisches System, Milz, Thymus Lehrbuch Pathologie Pathologie : das Lehrbuch Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer Interdisciplinary screening, diagnosis, therapy and follow-up of breast cancer : guideline of the DGGG and the DKG (S3-level, AWMF registry number 032/045OL, December 2017) – part 1 with recommendations for the screening, diagnosis and therapy of breast cancer Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) : Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer Interdisziplinäre Früherkennung, Diagnostik, Therapie und Nachsorge des Mammakarzinoms : Leitlinie der DGGG und DKG (S3-Level, AWMF-Registernummer 032/045OL, Dezember 2017) – Teil 1 mit Empfehlungen zur Früherkennung, Diagnostik und Nachsorge des Mammakarzinoms Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial Prognostic factors in the myoepithelial-like spindle cell type of metaplastic breast cancer 14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts 14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts Pathologie Pathologie A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition Pathologie : Mamma, Weibliches Genitale, Schwangerschaft und Kindererkrankungen Risikofaktoren und Prognose von T-Zell-Posttransplant lymphoproliferativen Erkrankungen : Reevaluation von 163 Fällen Pathologie : mit rund 150 Tabellen Arterioläre Hyalinose in Nierentransplantatbiopsien : Prävalenz und kliniko-pathologische Korrelation AGO Recommendations for the Diagnosis and Therapy of Breast Cancer Tumormorphogenese, Dickdarmkarzinom, update in pathology, die besten Forschungsbeiträge 2007 : mit 40 Tabellen ; gehalten in Magdeburg vom 30. Mai bis 2. Juni 2007 Prädiktive Pathologie : Begriffe - Fakten - neue Therapien - neue Diagnosen? ; Prostatakarzinom, Dickdarmadenom, Weichteiltumoren ; die besten Forschungsbeiträge 2006 ; mit 41 Tabellen ; gehalten in Berlin vom 19. bis 21. April 2006 Mammacarcinom, Ovarialcarcinom, entzündliche Lebererkrankungen, die besten Forschungsbeiträge 2005 : mit 43 Tabellen ; gehalten in Wuppertal vom 18. bis 21. Mai 2005 Andropathologie, Transplantationspathologie : die besten Forschungsbeiträge 2004 ; mit 32 Tabellen ; gehalten in Rostock vom 2. bis 5. Juni 2004

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Hans H. Kreipe (1956-)

Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2024

Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2024

ESR1 Liquid Biopsy im metastasierten Mammakarzinom bei endokriner Resistenz

Lehrbuch Pathologie

Pathologie : das Lehrbuch

AGO-Empfehlungen zur operativen Therapie des Mammakarzinoms: Update 2022

AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2023

Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2023

AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer: update 2023

Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer : Update 2023

Arbeitsgemeinschaft Gynäkologische Onkologie recommendations for the diagnosis and treatment of patients with early breast cancer: update 2023

Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial

ERBB2 mutation is associated with sustained tumor cell proliferation after short-term preoperative endocrine therapy in early lobular breast cancer

The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer—a pooled analysis of the randomised clinical trials PlanB and SUCCESS C

AGO-Empfehlungen zur operativen Therapie der Axilla nach neoadjuvanter Chemotherapie: Update 2021

AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2022

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2022

Ago recommendations for the surgical therapy of breast cancer: update 2022

AGO Recommendations for the surgical therapy of breast cancer: update 2022

Inter‐observer agreement for the histological diagnosis of invasive lobular breast carcinoma

Correction: AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update

AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update

AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2021

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2021

AGO Recommendations for the diagnosis and treatment of patients with early breast cancer: update 2021

AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer : update 2021

AGO recommendations for the surgical therapy of the axilla after neoadjuvant chemotherapy: 2021 Update

AGO recommendations for the surgical therapy of the Axilla after neoadjuvant chemotherapy: 2021 update

AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update

Immune cell composition and functional marker dynamics from multiplexed immunohistochemistry to predict response to neoadjuvant chemotherapy in the WSG-ADAPT-TN trial

Association of TILs with clinical parameters, Recurrence Score® results, and prognosis in patients with early HER2-negative breast cancer (BC)—a translational analysis of the prospective WSG PlanB trial

The run-in phase of the prospective WSG-ADAPT HR+/HER2-trial demonstrates the feasibility of a study design combining static and dynamic biomarker assessments for individualized therapy in early breast cancer

Correction to: Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial

AGO recommendations for the diagnosis and treatment of patients with early breast cancer: Update 2019

AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer: Update 2019

Knochenmark, Lymphatisches System, Milz, Thymus

Lehrbuch Pathologie

Pathologie : das Lehrbuch

Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer

Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer

Interdisciplinary screening, diagnosis, therapy and follow-up of breast cancer : guideline of the DGGG and the DKG (S3-level, AWMF registry number 032/045OL, December 2017) – part 1 with recommendations for the screening, diagnosis and therapy of breast cancer

Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer

Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) : Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer

Interdisziplinäre Früherkennung, Diagnostik, Therapie und Nachsorge des Mammakarzinoms : Leitlinie der DGGG und DKG (S3-Level, AWMF-Registernummer 032/045OL, Dezember 2017) – Teil 1 mit Empfehlungen zur Früherkennung, Diagnostik und Nachsorge des Mammakarzinoms

Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial

Prognostic factors in the myoepithelial-like spindle cell type of metaplastic breast cancer

14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts

14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts

Pathologie

Pathologie

A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition

Pathologie : Mamma, Weibliches Genitale, Schwangerschaft und Kindererkrankungen

Risikofaktoren und Prognose von T-Zell-Posttransplant lymphoproliferativen Erkrankungen : Reevaluation von 163 Fällen

Pathologie : mit rund 150 Tabellen

Arterioläre Hyalinose in Nierentransplantatbiopsien : Prävalenz und kliniko-pathologische Korrelation

AGO Recommendations for the Diagnosis and Therapy of Breast Cancer

Tumormorphogenese, Dickdarmkarzinom, update in pathology, die besten Forschungsbeiträge 2007 : mit 40 Tabellen ; gehalten in Magdeburg vom 30. Mai bis 2. Juni 2007

Prädiktive Pathologie : Begriffe - Fakten - neue Therapien - neue Diagnosen? ; Prostatakarzinom, Dickdarmadenom, Weichteiltumoren ; die besten Forschungsbeiträge 2006 ; mit 41 Tabellen ; gehalten in Berlin vom 19. bis 21. April 2006

Mammacarcinom, Ovarialcarcinom, entzündliche Lebererkrankungen, die besten Forschungsbeiträge 2005 : mit 43 Tabellen ; gehalten in Wuppertal vom 18. bis 21. Mai 2005

Andropathologie, Transplantationspathologie : die besten Forschungsbeiträge 2004 ; mit 32 Tabellen ; gehalten in Rostock vom 2. bis 5. Juni 2004